Does Urolithin A Actually Work?
Does Urolithin A Actually Work?
By Jaden Choi — a plain-English look at what the urolithin A trials actually measured, where the real signals are, and why the supplement's own studies keep missing their headline goals.
Urolithin A is the supplement industry's current favorite word for "anti-aging at the cellular level." Sold most visibly as Mitopure (the brand Timeline), it promises to renew your mitochondria — the tiny power plants inside your cells — and, by extension, to rebuild strength, stamina, and youthful energy. It sounds less like a pill and more like a software update for your body.
Here's the honest version up front. Urolithin A is a real molecule with a real, well-described mechanism, and unlike most "longevity" supplements it has actually been tested in several human randomized trials. Those trials show a consistent but modest pattern: measurable improvements in muscle strength, muscle endurance, and mitochondrial biomarkers — alongside a quietly awkward fact that the marketing skips. In trial after trial, the pre-specified main goal was not met, the studies were small, and the flagship one was run with involvement from the company that sells the ingredient. Let's separate the biology from the brochure.
- The mechanism is genuine: urolithin A is a gut-microbiome byproduct of foods like pomegranate and walnuts that triggers mitophagy — your cells' recycling of damaged mitochondria. Only about a third of people make meaningful amounts from food, which is the whole rationale for a supplement.
- A 2022 randomized trial in middle-aged adults found a significant ~12% gain in leg muscle strength — but its primary endpoint, peak power output, was not significantly improved.
- A separate 2022 trial in adults 65–90 found better muscle endurance and biomarkers, yet the 6-minute walk test and muscle ATP production did not beat placebo.
- Across the human studies, the effects are real but small, the samples are limited, and the headline trial involved the ingredient's maker — so "promising" is fair; "proven game-changer" is not.
What Urolithin A Actually Is
You can't buy urolithin A in a pomegranate. It's not in the fruit at all — it's what some of your gut bacteria make after you eat foods rich in compounds called ellagitannins: pomegranates, strawberries, raspberries, and walnuts. Your microbiome converts those raw materials, step by step, into urolithin A.
And here's the catch that quietly drives the entire supplement market: not everyone's gut can finish the job. Studies estimate only around 30–40% of people harbor the right bacterial mix to produce meaningful urolithin A from a normal diet. The rest are "non-producers" — they can eat pomegranates every day and still make almost none. Taking urolithin A directly skips the microbiome lottery entirely, which is the honest, legitimate reason a supplement might do something food can't for a given person.
The Mechanism: Spring-Cleaning Your Mitochondria
Mitochondria are the structures inside nearly every cell that turn food and oxygen into usable energy. As we age, damaged mitochondria accumulate, work less efficiently, and clog up the cell — a pattern tied to the fatigue and muscle loss that creep in with the decades.
Your cells have a built-in disposal system for this: mitophagy, the process that identifies worn-out mitochondria and recycles them so fresh ones can take over. Mitophagy naturally slows with age. In laboratory and animal studies, urolithin A reactivates mitophagy — essentially nudging cells to resume their spring-cleaning — and in those models it improved muscle function and endurance.
That's a genuinely elegant mechanism, and it's why scientists took the molecule seriously enough to run human trials in the first place. But a mechanism that works beautifully in a mouse or a petri dish is a hypothesis, not a result. The only question that matters for you is what happened when actual people took it.
Before a good trial starts, researchers name the one outcome they most expect to change — the primary endpoint. That's the honest test, because it's chosen in advance. Everything else is a secondary measure. When a study's primary endpoint misses but a secondary one improves, that secondary result is a hint worth following up, not proof — it's far easier for one of many secondary measures to turn positive by chance. Keep this distinction in mind: it's the difference between how these trials are often marketed and what they actually established.
The Flagship Trial: Middle-Aged Muscle (2022)
The study the marketing leans on hardest was published in Cell Reports Medicine in 2022. Researchers randomly assigned middle-aged adults to a placebo, 500 mg of urolithin A daily, or 1000 mg daily, and followed them for four months.
The good news is real: both urolithin A groups showed a statistically significant improvement of roughly 12% in leg muscle strength versus placebo, with no major side effects. On the cellular side, muscle samples showed increased mitophagy-related gene activity, and blood markers moved in a healthy direction — lower acylcarnitines (a sign of more efficient fat metabolism) and lower C-reactive protein (a marker of inflammation).
Now the part the tub doesn't mention. The study's pre-specified primary endpoint was peak power output during exercise — and on that headline measure, urolithin A did not significantly beat placebo. The authors themselves framed the study as proof-of-concept and called for larger confirmatory trials powered specifically for strength and endurance. It's also worth knowing that the author list included people affiliated with Amazentis (the company behind Timeline/Mitopure), so the flagship evidence is not independent of the seller. None of that makes the 12% strength gain fake — but it does mean the trial raised a flag, not a finish line.
The Older-Adult Trial: Endurance, With an Asterisk (2022)
A second 2022 randomized trial, published in JAMA Network Open, tested 1000 mg of urolithin A daily for four months in adults aged 65 to 90 — exactly the group that stands to gain most from better mitochondria.
The researchers reported that long-term supplementation was beneficial for muscle endurance (how long a muscle can keep working) and for several plasma biomarkers. That's a meaningful, real-world-relevant signal in older adults.
But again, the main functional outcomes fell short: the 6-minute walk distance — a classic, practical test of how far someone can actually get — and maximal ATP production in the hand muscle did not significantly differ from placebo. The trial was also small, and the participants were not a diverse group, which limits how widely the findings apply. The authors, appropriately, said the endurance finding needs confirmation.
The Safety Study and the Young-Lifter Trial
Two more human studies round out the picture. The first-in-human trial, published in Nature Metabolism in 2019, was essentially a safety check in healthy, sedentary older adults. Its job wasn't to prove benefits but to confirm that oral urolithin A is safe and well absorbed — which it did — while showing the same mitochondrial biomarker "signature" seen later. Useful groundwork, but biomarkers, not strength or stamina you'd feel.
More recently, a 2024 trial in the Journal of the International Society of Sports Nutrition gave 1 g a day for 8 weeks to a small group of resistance-trained young men. They improved on repetitions to failure and a measure of isometric strength versus placebo — but their one-rep-max on bench press and squat did not improve to a statistically significant degree. With only around 20 participants, it's a promising footnote, not a verdict.
Notice the pattern across all four: a real signal in some measure, paired with a miss on the most demanding or pre-specified one. That consistency is actually informative — it suggests urolithin A does something at the muscle-and-mitochondria level, but that the effect is modest enough to slip under the bar of the hardest tests.
The Evidence, Honestly Rated
| Claim | What the evidence shows | Strength |
|---|---|---|
| Activates mitophagy / improves mitochondrial biomarkers | Consistent across human trials (gene activity, acylcarnitines, CRP) | Well supported |
| Is safe and well absorbed | 2019 first-in-human + later trials: well tolerated, no major side effects | Well supported (short-term) |
| Increases muscle strength | ~12% leg-strength gain in middle-aged adults (2022); 1RM gains not significant in young men (2024) | Modest / mixed |
| Improves muscle endurance | Benefit reported in older adults (2022) and reps-to-failure in young men (2024) | Promising, unconfirmed |
| Improves real-world performance (peak power, 6-min walk) | Primary endpoints NOT significant in both 2022 trials | Not established |
| Extends lifespan / reverses aging in people | No human evidence; animal/cell data only | Not supported |
So Should You Bother?
Urolithin A sits in an unusual spot for a trendy supplement: the mechanism is sound, the human data exist, and the molecule appears safe in the short term. That already puts it ahead of most of the longevity aisle, where the evidence often stops at mice.
The sober read is that the effects demonstrated so far are real but small, concentrated in muscle strength and endurance and in cellular biomarkers — and that the most clinically meaningful, pre-chosen outcomes haven't yet been convincingly moved. The research is also young, the trials are small, and the flagship study wasn't independent of the manufacturer. If you're an older adult or someone noticing age-related dips in strength and energy, it's a defensible experiment with a reasonable safety profile — but go in expecting a modest nudge, not a transformation, and know the price is steep for an uncertain payoff.
And whatever urolithin A may add, it can't substitute for the interventions with mountains of evidence behind them. The most reliable way to renew your mitochondria is embarrassingly old-fashioned.
Frequently Asked Questions
Does urolithin A actually work?
Partly, and modestly. Human trials consistently show it activates mitophagy and improves mitochondrial biomarkers, and some studies found gains in muscle strength (about 12% in one middle-aged group) and endurance. But those same trials often missed their main pre-specified goals, such as peak power and the 6-minute walk, the samples were small, and the flagship trial involved the ingredient's maker. "Promising but not proven" is the fair summary.
Can't I just eat pomegranates instead?
Maybe — if your gut bacteria cooperate. Foods like pomegranate, berries, and walnuts provide the raw materials, but only an estimated 30–40% of people host the microbes that convert them into meaningful urolithin A. If you're a "non-producer," eating more of those foods won't raise your levels much, which is the main argument for taking it directly. There's no easy home test to know which group you're in.
Is urolithin A the same as Mitopure?
Mitopure is a branded, purified form of urolithin A sold by the company Timeline, and it's the exact ingredient used in the main human trials. Other brands also sell urolithin A. Because supplements aren't tightly regulated for purity or dose, the form and amount in a given product can vary, and most of the published evidence specifically used the branded ingredient at 500–1000 mg per day.
Does it actually slow aging or extend lifespan?
There's no human evidence for that. Lifespan extension has been shown only in animals and lab models. In people, the studies measured muscle and mitochondrial markers over a few months — not aging or longevity. Treat "anti-aging" language as marketing extrapolation from cell and animal data, not a demonstrated human outcome.
Is it safe to take?
In the trials, urolithin A was generally well tolerated over a few months with no major side effects reported. That said, long-term safety data are limited, supplements aren't tightly regulated, and no study has tested it during pregnancy or alongside most medications. If you're pregnant or nursing, take medication, or have a medical condition, talk to your doctor before starting it.
Bottom Line — What the Research Actually Supports
Urolithin A is one of the few longevity-aisle ingredients that has graduated from mouse studies to real human trials — which earns it an honest hearing rather than hype or reflexive dismissal:
- The mechanism is legitimate: it reactivates mitophagy, your cells' mitochondrial recycling system, and only about a third of people make much of it from food.
- The human benefits are real but modest: improvements in muscle strength, endurance, and mitochondrial biomarkers — repeatedly paired with missed primary endpoints and small samples.
- The biggest claims aren't backed in people: "reverses aging" and "extends lifespan" rest on animal data, not human outcomes.
So does urolithin A actually work? Fairly stated: it does measurable things to your muscles and mitochondria, but the proven effects are small, the strongest trials missed their main targets, and the flagship study wasn't independent. It's a reasonable, low-risk experiment for an older adult who understands they're buying a modest, uncertain edge at a premium price — not a shortcut to youth. The interventions that most reliably keep your mitochondria young are still the unglamorous ones: regular resistance and endurance exercise, enough protein, decent sleep, and not smoking. Urolithin A, at best, is a small supporting act — not the headliner the label implies.
Sources
- Singh A, D'Amico D, Andreux PA, et al. "Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults." Cell Reports Medicine, 2022;3(5):100633 (randomized, double-blind, placebo-controlled; 500/1000 mg/day for 4 months; significant ~12% leg-strength gain and improved mitochondrial/inflammation biomarkers, but the primary endpoint — peak power output — was not significantly improved; authors include Amazentis/Timeline affiliates). DOI: 10.1016/j.xcrm.2022.100633 · PMC9133463
- Liu S, D'Amico D, Shankland E, et al. "Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial." JAMA Network Open, 2022;5(1):e2144279 (adults 65–90; 1000 mg/day for 4 months; improved muscle endurance and plasma biomarkers, but 6-minute walk distance and maximal muscle ATP production were not significantly different from placebo; small sample). DOI: 10.1001/jamanetworkopen.2021.44279
- Andreux PA, Blanco-Bose W, Ryu D, et al. "The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans." Nature Metabolism, 2019;1:595–603 (first-in-human randomized placebo-controlled study; established oral safety and a mitochondrial biomarker signature, not clinical performance outcomes). DOI: 10.1038/s42255-019-0073-4
- 2024 randomized, double-blind, placebo-controlled trial in resistance-trained young men, Journal of the International Society of Sports Nutrition (1 g/day urolithin A for 8 weeks; improved repetitions-to-failure and isometric strength vs placebo, but bench-press and squat one-rep-max gains were not statistically significant; ~20 participants). PMC11536656
This article summarizes published research for general educational purposes and is not medical advice. It does not diagnose, treat, or recommend any specific supplement, dose, or treatment, and urolithin A is not a proven treatment for aging, muscle loss, or any disease. Research evolves and findings can be revised. If you are considering a supplement — especially if you are pregnant or nursing, take medication, or have a medical condition — talk to your doctor or a licensed healthcare provider before making any change. Information is current as of October 2026.